WPRIM Management System> DCMS> Journal of Gynecologic Oncology> 2018> 29> 5

Volume: 29 Issue: 5

1. Efficacy of palonosetron plus dexamethasone in preventing chemotherapy-induced nausea and emesis in patients receiving carboplatin-based chemotherapy for gynecologic cancers: a phase II study by the West Japan Gynecologic Oncology Group (WJGOG 131). Page:e77—
2. The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients. Page:e72—
3. Treatment outcomes of patients with stage II pure endometrioid-type endometrial cancer: a Taiwanese Gynecologic Oncology Group (TGOG-2006) retrospective cohort study. Page:e76—
4. Burden of cervical neoplasia in mid-western rural Nepal: a population-based study. Page:e64—
5. Using low-coverage whole genome sequencing technique to analyze the chromosomal copy number alterations in the exfoliative cells of cervical cancer. Page:e78—
6. Treatment outcomes of high-dose-rate intracavitary brachytherapy for cervical cancer: a comparison of Ir-192 versus Co-60 sources. Page:e86—
7. Prognostic impact of reduced tumor-free margin distance on long-term survival in FIGO stage IB/II vulvar squamous cell carcinoma. Page:e61—
8. A triage strategy in advanced ovarian cancer management based on multiple predictive models for R0 resection: a prospective cohort study. Page:e65—
9. Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer. Page:e66—
10. Clinical associations of Trousseau's syndrome associated with cerebral infarction and ovarian cancer. Page:e67—
11. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer. Page:e69—
12. Negative peritoneal washing cytology during interval debulking surgery predicts overall survival after neoadjuvant chemotherapy for ovarian cancer. Page:e70—
13. Teenage pregnancy complicated by primary invasive ovarian cancer: association for oncologic outcome. Page:e79—
14. The influence of surgeon volume on outcomes after pelvic exenteration for a gynecologic cancer. Page:e68—
15. A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancer. Page:e81—
16. Erratum: Prevalence of germline BRCA mutations among women with carcinoma of the peritoneum or fallopian tube. Page:e80—
17. Lynch syndrome – Muir-Torre variant: implication in gynecologic oncology. Page:e84—